Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2008
10/07/2008US7432357 Anti-cancer antibodies with reduced complement fixation
10/07/2008US7432356 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
10/07/2008US7432354 Polypeptide or fragment recognized by tumor-specific cytotoxic T lymphocytes; anticancer vaccines
10/07/2008US7432346 Gene expressed in prostate cancer
10/07/2008US7432344 Porcine CTLA-4 for xenograft-specific immunosuppression
10/07/2008US7432253 Phosphoepoxides, method for making same and uses
10/07/2008US7432244 Administering peptides useful in treating disorders caused or mediated by insulin-like growth factors, such as cancer, diabetic complications, acromegaly, age-related macular degeneration, ischemic injuries, or traumas
10/07/2008US7432101 Production of poxviruses with adherent or non adherent avian cell lines
10/07/2008US7432081 Nucleotide sequences coding protein for use the prevention of bacterial infections
10/07/2008US7432077 High-affinity choline transporter
10/07/2008US7432065 Microarray for identifying regulator peptides which bind and regulate modular protein domain (PDZ) interactions with hematopoietic cells for use in treatment of autoimmune, cell proliferative and nervous system disorders; peptide mimetics
10/07/2008US7432059 Methods of identifying compounds that upmodulate T cell activation in the presence of a PD-1 mediated signal
10/07/2008US7432045 Membrane transiting peptides having antiviral properties; respiratory disorders
10/07/2008US7431936 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
10/07/2008US7431934 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
10/07/2008US7431933 Viricide resistant hepatitis b; drug design and screening; genetic vaccines
10/07/2008US7431932 Infecting the mixed cellular compositions with reovirus which selectively lyse the ras-mediated neoplastic cells in the mixed composition; reducing the risk of introducing or reintroducing neoplastic cells into the recipient
10/07/2008US7431931 Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions
10/07/2008US7431930 Neutralizing epitopes for viruses
10/07/2008US7431929 For eliciting an immune response to smallpox virus ; vaccines having an increased level of safety, recombinant vaccinia viruses containing an inactivated E3L region
10/07/2008US7431928 Immunogenic peptide of given amino acid sequence incorporated in support or carrier; isolating human leukocyte antigen cells from lymphoid or myeloid cells; induction of cytotoxic response
10/07/2008US7431927 TNFα-neutralizing antibodies
10/07/2008US7431926 Tumor supressor gene p33ING2
10/07/2008US7431925 Internal image antibodies for optical imaging and therapy
10/07/2008US7431924 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal
10/07/2008US7431923 Cytotoxicity mediation of cells evidencing surface expression of CD63
10/07/2008CA2440659C Methods and apparatus for selectively processing eggs having identified characteristics
10/07/2008CA2350834C N-terminally truncated her-2/neu protein as a cancer prognostic indicator
10/07/2008CA2338646C Microparticles with adsorbent surfaces, methods of making same, and uses thereof
10/07/2008CA2264496C Fungal antigens and process for producing the same
10/07/2008CA2218515C Monoclonal antibodies against hiv-1 and vaccines made thereof
10/07/2008CA2149319C Haemophilus outer membrane protein
10/07/2008CA2148563C Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain
10/07/2008CA1341582C Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
10/05/2008CA2583999A1 Characterization of a mekk binding site and uses thereof
10/02/2008WO2008119071A1 Modulation of tumor microenvironment
10/02/2008WO2008118926A1 A non-destructive method to quantify and isolate antigen-specific b cells and uses thereof
10/02/2008WO2008118902A1 Vaccination against multiple serotypes of pasteurella multocida
10/02/2008WO2008118861A2 Discrete size and shape specific organic nanoparticles designed to elicit an immune response
10/02/2008WO2008118792A2 Gamma delta t cells and methods of treatment of interleukin-17 related conditions
10/02/2008WO2008118752A2 Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides
10/02/2008WO2008118736A1 Combined human il- 18 and anti cd20 antibody cancer treatment
10/02/2008WO2008118711A2 Method of inhibiting complement activation with human anti-factor c3 antibodies and use thereof
10/02/2008WO2008118691A2 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
10/02/2008WO2008118592A2 Use of an avirulent bordetella mutant as a live vaccine vector
10/02/2008WO2008118587A2 Therapeutic applications of activation of human antigen-presenting cells through dectin-1
10/02/2008WO2008118497A1 Rhadinovirus vectors for expressing of immunodeficiency virus antigen
10/02/2008WO2008118487A2 Compositions and methods for incresing immunogenicity of glycoprotein vaccines
10/02/2008WO2008118470A2 Acute transmitted hiv envelope signatures
10/02/2008WO2008118255A1 Methods of releasing sporocysts from oocysts using controlled shear forces
10/02/2008WO2008118118A1 Artificial invaplex
10/02/2008WO2008118017A2 Prame derived peptides and immunogenic compositions comprising these
10/02/2008WO2008117970A1 Use of inhibitors of leukotriene b4 receptor blt2 for treating human cancers
10/02/2008WO2008117313A1 Polymer particles based vaccine
10/02/2008WO2008116936A1 Use of an adjuvanted allergy vaccine formulation for parenteral administration
10/02/2008WO2008116916A1 Synbiotic to improve gut microbiota
10/02/2008WO2008116907A1 Probiotics to reduce development of allergy in infants born by caesarean section
10/02/2008WO2008116904A1 Probiotics to reduce episodes of diarrhoea in infants born by caesarean section
10/02/2008WO2008116892A1 Probiotics to improve gut microbiota
10/02/2008WO2008116775A1 Polypeptide recognized by anti hiv-1 gp41 antibodies isolated from highly hiv-1 exposed, non infected women
10/02/2008WO2008116468A2 Mhc peptide complexes and uses thereof in infectious diseases
10/02/2008WO2008116380A1 A vaccine preventing and/or treating autoimmune diseases
10/02/2008WO2008116368A1 A method for preparing antigens of foot-and-mouth disease virus
10/02/2008WO2008116347A1 Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
10/02/2008WO2008116316A1 Vector encoding therapeutic polypeptide and safety elements to clear transduced cells
10/02/2008WO2008116299A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
10/02/2008WO2008116265A1 Peptides with anitfungal activity
10/02/2008WO2008098115A3 Optimized igf-1r antibodies and methods of using the same
10/02/2008WO2008091798A3 Optimized ca9 antibodies and methods of using the same
10/02/2008WO2008086612A8 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity
10/02/2008WO2008078056A3 Method for amplifying hcv in aedes mosquitoes
10/02/2008WO2008073463A3 Methods and compositions for treating and monitoring treatment of il-13-associated disorders
10/02/2008WO2008067995A3 Means and method for raising improved immune response
10/02/2008WO2008064321A3 Methods of treating chronic inflammatory diseases using a gm-csf antagonist
10/02/2008WO2008063291A3 Polypeptide ligands for targeting cartilage and methods of use thereof
10/02/2008WO2008058127A3 Agonist trkb antibodies and uses thereof
10/02/2008WO2008036437A3 Novel gene disruptions, compositions and methods relating thereto
10/02/2008WO2008036147A9 Drug delivery with stimulus responsive biopolymers
10/02/2008WO2008017826A3 Immunogenic proteins of burkholderia pseudomallei and uses thereof
10/02/2008WO2008009088B1 Vaccine composition and immunization method
10/02/2008WO2007149287A3 Transfer factor compositions and methods
10/02/2008WO2007145840A3 Compositions and methods for diagnosing and treating cancer
10/02/2008WO2007134327A3 Neutralizing antibodies to influenza viruses
10/02/2008WO2007124106A3 Application of antl-apoptotic genes in mammalian cells for perfusion culture.
10/02/2008WO2007120823A3 Uses and compositions for treatment of psoriasis
10/02/2008WO2007117685A3 Conjugates of an anti-tnf-alpha antibody
10/02/2008WO2007106744A8 Anti-5t4 antibodies and uses thereof
10/02/2008WO2007084568A3 Heteroduplex tracking assay
10/02/2008WO2007073499A3 Epha2 bite molecules and uses thereof
10/02/2008WO2005079490A3 Methods of therapy and diagnosis using targeting of cells that express steap2 polypeptides
10/02/2008US20080242630 Fusion proteins of mycobacterium tuberculosis
10/02/2008US20080242605 Prevent binding of formyl methionine-leucine-phenylalanine and, or protein to granulocytes; antiinflammatory agents; viricides; HIV infections
10/02/2008US20080242601 Selective Inhibition of Nf-Kappab Activiation by Peptides Designed to Disrupt Nemo Oligomerization
10/02/2008US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same
10/02/2008US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
10/02/2008US20080241924 Using cell adhesion molecule specific immunoglobulin for prevention and treatment of colon, breast and cervical cancers
10/02/2008US20080241923 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulin for treatment and prevention of viral infection, inflammatory, autoimmune, graft rejection and cardivascular disorders
10/02/2008US20080241861 Biological materials and methods useful in the diagnosis and treatment of diseases
10/02/2008US20080241859 Using aglycoprotein 10B antibody as diagnostic tool in detection of cell proliferative disorders associated with chronic viral diseases
10/02/2008US20080241857 Netrin receptors
1 ... 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 ... 1823